回复：关于“硫唑嘌呤与霉酚酸酯用于初治自身免疫性肝炎诱导缓解的开放标签随机对照试验”的评论 - Suppr

Reply to: Comments on "An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis".

作者信息

Snijders Romée J A L M, Stoelinga Anna E C, van Hoek Bart, Drenth Joost P H

机构信息

Department of Gastroenterology and Hepatology, Radboudumc, Nijmegen, the Netherlands; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Germany.

Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.

出版信息

J Hepatol. 2024 Jul;81(1):e43-e44. doi: 10.1016/j.jhep.2024.03.038. Epub 2024 Mar 28.

DOI:10.1016/j.jhep.2024.03.038

PMID:38554845

Abstract

摘要

相似文献

Reply to: Comments on "An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis".

J Hepatol. 2024 Jul;81(1):e43-e44. doi: 10.1016/j.jhep.2024.03.038. Epub 2024 Mar 28.

An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis.

J Hepatol. 2024 Apr;80(4):576-585. doi: 10.1016/j.jhep.2023.11.032. Epub 2023 Dec 14.

Autoimmune hepatitis: Azathioprine or mycophenolate mofetil for inducing remission?

J Hepatol. 2024 Jul;81(1):e38-e39. doi: 10.1016/j.jhep.2024.02.012. Epub 2024 Feb 23.

A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis.

Aliment Pharmacol Ther. 2016 May;43(10):1035-47. doi: 10.1111/apt.13584. Epub 2016 Mar 16.

Autoimmune hepatitis: Mycophenolate mofetil vs. azathioprine as first-line therapy.

J Hepatol. 2024 Jul;81(1):e41-e42. doi: 10.1016/j.jhep.2024.02.022. Epub 2024 Mar 6.

Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial.

Trials. 2022 Dec 13;23(1):1012. doi: 10.1186/s13063-022-06890-w.

Comparative effectiveness of azathioprine or mycophenolate mofetil as an adjuvant for the treatment of bullous pemphigoid.

Arch Dermatol. 2008 Jul;144(7):946. doi: 10.1001/archderm.144.7.946-a.

Mycophenolate mofetil for the induction of remission in primary biliary cholangitis with predominant features of autoimmune hepatitis.

J Hepatol. 2024 Jul;81(1):e35-e36. doi: 10.1016/j.jhep.2024.01.020. Epub 2024 Feb 1.

A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.

Arch Dermatol. 2007 Dec;143(12):1536-42. doi: 10.1001/archderm.143.12.1536.

Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis.

Hum Pathol. 2004 Apr;35(4):509-12. doi: 10.1016/j.humpath.2003.10.017.

引用本文的文献

What is the optimal first-line treatment of autoimmune hepatitis? A systematic review with meta-analysis of randomised trials and comparative cohort studies.

BMJ Open Gastroenterol. 2025 Mar 28;12(1):e001549. doi: 10.1136/bmjgast-2024-001549.

Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial.

Trials. 2024 Jan 17;25(1):61. doi: 10.1186/s13063-023-07832-w.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Reply to: Comments on "An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis".

作者信息

Snijders Romée J A L M, Stoelinga Anna E C, van Hoek Bart, Drenth Joost P H

机构信息

Department of Gastroenterology and Hepatology, Radboudumc, Nijmegen, the Netherlands; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Germany.

Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.

出版信息

J Hepatol. 2024 Jul;81(1):e43-e44. doi: 10.1016/j.jhep.2024.03.038. Epub 2024 Mar 28.

DOI:10.1016/j.jhep.2024.03.038

PMID:38554845

Abstract

摘要

Reply to: Comments on "An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis".

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Reply to: Comments on "An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis".

作者信息

机构信息

出版信息

相似文献

引用本文的文献